CTVACorteva
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−82% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 5). Price is −82% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 16% since the previous count, up from 2.7% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CTVA is trading
Corteva is +7.9% over the past year while the S&P 500 is +18%: 10 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −82%
vs 200-day average · a clear downtrend
- RSI (14)
- 5
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 85%
Below its 52-week high
Details›
- Last close2026-10-09
- $77.67
- 1 monthS&P 500 +2.7%
- −8.3%
- 1 yearS&P 500 +18%
- +7.9%
- 5 yearsS&P 500 +88%
- +84%
- vs 50-day average$71.61
- −82%
- 52-week high
- $89.97
- 52-week low
- $11.92
- Annualised volatility
- 66%
| Year | Return |
|---|---|
| 2026 (year to date) | −80% |
| 2025 | +19% |
| 2024 | +20% |
| 2023 | −18% |
| 2022 | +26% |
| 2021 | +24% |
| 2020 | +33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 5 of 7 | +4.3% |
| Feb | 7 | 4 of 7 | +5.4% |
| Mar | 7 | 5 of 7 | +1.4% |
| Apr | 7 | 4 of 7 | +0.98% |
| May | 7 | 4 of 7 | +1.3% |
| Jun | 8 | 4 of 8 | +0.45% |
| Jul | 8 | 5 of 8 | +2.5% |
| Aug | 8 | 5 of 8 | −0.01% |
| Sep | 8 | 3 of 8 | −3.4% |
| Oct | 8 | 4 of 8 | −8.6% |
| Nov | 7 | 5 of 7 | +4.2% |
| Dec | 7 | 4 of 7 | +0.66% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Basic Materials
Ranks #96 of 179 by RyuScore